Form 4: Surgery Partners Director Clifford Adlerz Acquires 6,861 Shares in Equity Grant

Surgery Partners, Inc. Director Clifford G. Adlerz reported the acquisition of 6,861 shares of common stock at a price of $23.32 per share, increasing his direct beneficial ownership to 57,434 shares, with vesting scheduled for June 2026.

Summary

• Clifford G. Adlerz, a Director of Surgery Partners, Inc. (SGRY), acquired 6,861 shares of common stock.
• The transaction occurred on June 10, 2025, at a price of $23.32 per share.
• Following this acquisition, Mr. Adlerz directly beneficially owns 57,434 shares of Surgery Partners common stock.
• The acquired shares are subject to a vesting schedule, with full vesting set for June 10, 2026.

Sentiment

Score: 7

Explanation: The acquisition of shares by a director, even if an equity grant, generally indicates alignment of interests and confidence in the company's future, which is a positive signal for investors. There are no negative disclosures within the filing.

Positives

• Director Clifford G. Adlerz increased his direct beneficial ownership in Surgery Partners, Inc. by acquiring 6,861 shares, aligning his interests further with shareholders.
• The acquisition of shares by a director, particularly through an equity grant, can signal confidence in the company's future prospects and commitment to long-term value creation.

Negatives

• No negative information was disclosed in this Form 4 filing.

Risks

• The 6,861 acquired shares are subject to a vesting period until June 10, 2026, meaning the director does not have full, unrestricted ownership rights until that date.

Future Outlook

This Form 4 filing primarily reports an insider transaction and does not contain forward-looking statements or guidance regarding the company's future financial performance or strategic outlook, beyond the specified vesting date for the acquired shares.

Industry Context

This filing reports a routine insider equity grant to a director within the healthcare services industry. Such grants are common compensation practices aimed at aligning management incentives with shareholder interests. It does not provide broader industry trends or competitive analysis.

Comparison to Industry Standards

• This Form 4 filing details an equity grant to a director, which is a standard compensation practice across industries, including healthcare services.
• The specific terms, such as the number of shares and vesting schedule, are typical for director compensation packages, though direct comparisons to specific companies like HCA Healthcare, Tenet Healthcare, or Universal Health Services would require detailed compensation plan disclosures for those entities, which are not provided in this document.
• The acquisition price of $23.32 per share reflects the market price at the time of the grant, consistent with common equity compensation practices.

Related Party Transactions

• The acquisition of shares by a director (Clifford G. Adlerz) from the issuer (Surgery Partners, Inc.) constitutes a related party transaction, common for equity compensation arrangements.

Stakeholder Impact

• Shareholders: The increased ownership by a director aligns management's interests with those of shareholders, potentially fostering better long-term decision-making and demonstrating confidence in the company's future.

Next Steps

• The acquired shares are scheduled to vest on June 10, 2026, at which point the director will gain full ownership rights.

Key Dates

Recommendation

Keywords

Surgery Partners, SGRY, SEC Form 4, Insider Transaction, Stock Acquisition, Director Ownership, Equity Grant, Clifford G. Adlerz, Healthcare Services